Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
Clinical trial NCT02012218 · COMPLETED
Trial details
- NCT number
- NCT02012218
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-10-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.